Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Biologics Safety Testing Companies

Biologics safety testing is a crucial process in the development and manufacturing of biopharmaceuticals to ensure the safety, purity, and efficacy of these complex biological products. Companies specializing in biologics safety testing provide a range of services to assess the quality and safety of biopharmaceutical products.

Biologics safety testing companies

Latest Biologics safety testing Companies Updates:

Jan 2024

Thermo Fisher Scientific (US) Launched their QMS™ QSight™ Mass Spectrometer, offering enhanced sensitivity and speed for detecting residual host-cell proteins and impurities in biologics.Acquired Brammer Bio, a contract testing organization specializing in bioburden and sterility testing, strengthening their market position.

Charles River Laboratories (US) Expanded their global network of biologics safety testing facilities with new labs in China and India to cater to the growing demand in emerging markets.Developed new in vivo models for assessing the immunogenicity of biologics and predicting potential reactions in human patients.

Lonza (Switzerland) Collaborated with a leading biopharmaceutical company to develop a custom endotoxin testing solution for a novel cell therapy product.Launched their PyroTec PRO+ Automated Robotic Solution, offering increased automation and efficiency for endotoxin testing workflows.

Eurofins Scientific (France) Received accreditation for their new cell and gene therapy testing laboratory, expanding their service offerings for emerging biotherapeutic modalities.Partnered with an academic institution to develop a novel assay for detecting viral impurities in cell-based therapies.

List of Biologics safety testing Key companies in the market

BioPharma

Redberry

Eurofins Scientific

Lonza Group Ltd

Charles River Laboratories International Inc.

Promega Corporation

Thermo Fisher Scientific

Microsoft Biotechnologie GnbH

BioRad Laboratories Inc.

Samsung Biologics

Biologics Safety Testing Market Highlights:

Biologics Safety Testing Market Size

Biologics Safety Testing Market Trends

Biologics Safety Testing Market Analysis

Biologics Safety Testing Market Share

Biologics Safety Testing Market Highlights:

Biologics Safety Testing Market Trends

Biologics Safety Testing Market Analysis

Biologics Safety Testing Market Share

Biologics Safety Testing Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.